SCHEMBL4875370

SCHEMBL4875370

NCCc1c(-c2ccccc2)[nH]c2ccccc12

nearest known ligand 0.70

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.70
HTR2A P28223 6/20 0.64
HTR2C P28335 5/20 0.64
CNR1 P21554 1/20 0.60
DRD2 P14416 2/20 0.59
KDM4E B2RXH2 1/20 0.57
MEN1 O00255 1/20 0.57
ALDH1A1 P00352 1/20 0.57
MAPT P10636 1/20 0.57
KMT2A Q03164 1/20 0.57
ESR1 P03372 1/20 0.52
ESR2 Q92731 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5130227 0.98 HTR6 (0.68) HTR6HTR2AHTR2CCNR1DRD2
Cyanide SCHEMBL28580911 0.95 HTR6 (0.65) HTR6HTR2AHTR2CCNR1DRD2
SCHEMBL22221978 0.93 HTR6 (0.61) HTR6HTR2AHTR2CCNR1DRD2
SCHEMBL14074161 0.87 HTR2A (0.63) HTR6HTR2AHTR2CCNR1DRD2
SCHEMBL6476562 0.85 HTR6 (0.55) HTR6HTR2AHTR2CCNR1DRD2
SCHEMBL22221974 0.85 HTR6 (0.55) HTR6HTR2AHTR2CCNR1DRD2
SCHEMBL7613059 0.83 KDM4E (0.64) HTR6HTR2AHTR2CKDM4EALDH1A1
SCHEMBL2789743 0.83 HTR6 (0.71) HTR6HTR2AHTR2CCNR1DRD2
SCHEMBL7995810 0.82 GNRHR (0.54)
SCHEMBL10933049 0.82 HTR2A (0.69) HTR2AHTR2CCNR1DRD2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625919-B2 4-azasteroid derivatives as androgen receptor modulators MERCK & CO., INC. (US) 2009-12-01 US disclosed
US-7625919-B2 4-azasteroid derivatives as androgen receptor modulators MERCK & CO., INC. (US) 2009-12-01 US disclosed
US-20080262035-A1 Amide Derivatives as Inhibitors of Histone Deacetylase MERCK & CO., INC. 2008-10-23 US disclosed
US-20080221157-A1 Amide Derivatives as Inhibitors of Histone Deacetylase ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGE (IT) 2008-09-11 US disclosed
CN-101107220-A Amide derivatives as inhibitors of histone deacetylase ANGELETTI P INST RICHERCHE BIO (IT) 2008-01-16 CN disclosed
EP-1768955-A1 AMIDE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2007-04-04 EP disclosed
EP-1768956-A1 AMIDE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2007-04-04 EP disclosed
WO-2006005941-A1 AMIDE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI S.P.A. (IT) 2006-01-19 WO disclosed
WO-2006005955-A1 AMIDE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2006-01-19 WO disclosed
US-6486153-B1 Phenylindole derivatives as 5-HT2A receptor ligands MERCK SHARP & DOHME LTD. 2002-11-26 US disclosed
WO-1999011619-A1 PHENYLINDOLE DERIVATIVES AS 5-HT2A RECEPTOR LIGANDS MERCK SHARP & DOHME LIMITED (GB) 1999-03-11 WO disclosed
EP-0892963-A1 METHOD OF CREATING AND SEARCHING A MOLECULAR VIRTUAL LIBRARY USING VALIDATED MOLECULAR STRUCTURE DESCRIPTORS Patterson, David E. (US) 1999-01-27 EP disclosed
WO-1997027559-A1 METHOD OF CREATING AND SEARCHING A MOLECULAR VIRTUAL LIBRARY USING VALIDATED MOLECULAR STRUCTURE DESCRIPTORS PATTERSON DAVID E (US) 1997-07-31 WO disclosed
EP-0623138-B1 NEW ADENOSINE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM UNION PHARMA SCIENT APPL (FR) 1997-05-21 EP disclosed
US-5480983-A ANALGESICS, HYPOTENSIVE AGENTS LABORATOIRES UPSA (FR) 1996-01-02 US disclosed
EP-0623138-A1 NEW ADENOSINE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. UNION PHARMA SCIENT APPL (FR) 1994-11-09 EP disclosed
WO-1993014102-A1 NEW ADENOSINE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LABORATOIRES UPSA (FR) 1993-07-22 WO disclosed
US-3956267-A Indole-containing disazo dyestuffs having a sulfatoalkyleneoxy-substituent BAYER AKTIENGESELLSCHAFT (DT) 1976-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080262035-A1 Amide Derivatives as Inhibitors of Histone Deacetylase HDAC1, HDAC5, HDAC11 HTR6 1039/4885HTR2A 1259/4885HTR2C 1994/4885
US-20080221157-A1 Amide Derivatives as Inhibitors of Histone Deacetylase HDAC1, HDAC5, HDAC4 HTR6 1664/4885HTR2A 2204/4885HTR2C 2870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.